HLS Therapeutics Inc
TSX:HLS
HLS Therapeutics Inc
Capital Expenditures
HLS Therapeutics Inc
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
HLS Therapeutics Inc
TSX:HLS
|
Capital Expenditures
-$191k
|
CAGR 3-Years
82%
|
CAGR 5-Years
28%
|
CAGR 10-Years
4%
|
|
M
|
Manitex Capital Inc
XTSX:MNX
|
Capital Expenditures
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is HLS Therapeutics Inc's Capital Expenditures?
Capital Expenditures
-191k
USD
Based on the financial report for Mar 31, 2024, HLS Therapeutics Inc's Capital Expenditures amounts to -191k USD.
What is HLS Therapeutics Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
4%
Over the last year, the Capital Expenditures growth was -74%. The average annual Capital Expenditures growth rates for HLS Therapeutics Inc have been 82% over the past three years , 28% over the past five years , and 4% over the past ten years .